-
-
-
-
-
-
-
Foghorn Therapeutics (FHTX) Reiterated at Buy by Stifel After Q4 Results
-
-
-
-
-
-
-
Guggenheim Starts Foghorn Therapeutics (FHTX) at Buy
-
-
-
-
-
-
-
Citizens JMP Starts Foghorn Therapeutics (FHTX) at Market Outperform
-
-
-
-
-
-
-
Foghorn Therapeutics (FHTX) PT Lowered to $14 at Jefferies
-
-
-
-
-
-
-
Jefferies Starts Foghorn Therapeutics (FHTX) at Buy
-
-
415,025 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

